Vatelizumab

'Vatelizumab' - 1 News Result(s)

  • Glenmark, Sanofi End Pact for New Multiple Sclerosis Therapy
    Business | Press Trust of India | Thursday October 29, 2015
    Glenmark Pharmaceuticals' licensing deal with Sanofi for a new molecule - Vatelizumab - aimed at treating multiple sclerosis (MS) has ended with the French drug major deciding against pursuing it as the molecule did not meet the primary efficacy endpoint.
    www.ndtv.com/business

'Vatelizumab' - 1 News Result(s)

  • Glenmark, Sanofi End Pact for New Multiple Sclerosis Therapy
    Business | Press Trust of India | Thursday October 29, 2015
    Glenmark Pharmaceuticals' licensing deal with Sanofi for a new molecule - Vatelizumab - aimed at treating multiple sclerosis (MS) has ended with the French drug major deciding against pursuing it as the molecule did not meet the primary efficacy endpoint.
    www.ndtv.com/business
Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com